Oncologists Must Help Patients Overcome Fear of Genetic Testing to Uncover Cancer Risks
March 13th 2014In the current digital age, where all-too-personal information flows from Facebook and Twitter, it seems that the health information available through the process of genetic testing would be an idea welcomed by most of the public.
Minimizing Axillary Surgery for Patients With Node-Positive Breast Cancer
March 6th 2014As advances in systemic therapy improve our ability to individualize breast cancer treatment, and improve response rates and outcomes, it is important to reevaluate the most appropriate form of local-regional management.
Idelalisib Shows Promising Activity in Heavily Pretreated iNHL
February 26th 2014Treatment with the oral PI3K-delta inhibitor idelalisib produced an overall response rate of 57% with an average response duration of 12.5 months in heavily pretreated patients with indolent non-Hodgkin's lymphoma.
Genetic Analysis of Remote Population May Advance Breast Cancer Prevention and Treatment
February 18th 2014Using blood samples collected from the Andean villagers, the laboratory at the UC Davis Genome Center uses a variety of high-throughput genetic analysis techniques to screen for genetic differences.